Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 10.08.2026 1 Brain Res 6 J Neural Transm (Vienna) 7 Mov Disord 1 Neurobiol Dis 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain Res

1. SHI S, Liu R, Liu C, Chen Y, et al
   Mitochondria-enriched BMSC exosomes restore microglia-neuron cross-talk in Parkinson's disease via PINK1/parkin and PI3K/Akt/mTOR pathways.
   Brain Res. 2026 Aug 5:150487. doi: 10.1016/j.brainres.2026.150487.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

2. PELICIONI PHS, Waller S, Chan L, Krishnan AV, et al
   Real-world gait changes preceding Parkinson's disease diagnosis in a population-scale UK biobank cohort.
   J Neural Transm (Vienna). 2026 Aug 8. doi: 10.1007/s00702-026-03256.
   PubMed         Abstract available
   
   
3. HOLTBERND F, Classen J, Kohl Z, Potter-Nerger M, et al
   Quality management and specifications of multidisciplinary Parkinson's disease management: an expert opinion.
   J Neural Transm (Vienna). 2026 Aug 7. doi: 10.1007/s00702-026-03260.
   PubMed         Abstract available
   
   
4. SERMENSE YNA, Rosales RL, Tanglao MJ
   Add-on safinamide and amantadine in Filipino Parkinson's disease patients with motor fluctuations: a retrospective exploratory cohort study.
   J Neural Transm (Vienna). 2026 Aug 4. doi: 10.1007/s00702-026-03246.
   PubMed         Abstract available
   
   
5. HOGLINGER G, Hopfner F
   Toward the prevention of clinically manifest Parkinson's disease.
   J Neural Transm (Vienna). 2026 Aug 4. doi: 10.1007/s00702-026-03240.
   PubMed         Abstract available
   
   
6. PHOKAEWVARANGKUL O, Jost WH, Bhidayasiri R
   What's in a name? reframing advanced Parkinson's disease as a multidimensional state.
   J Neural Transm (Vienna). 2026 Aug 1. doi: 10.1007/s00702-026-03257.
   PubMed         Abstract available
   
   
7. FEARON C, Jost WH, Roth J, Rozankovic PB, et al
   Non-pharmacological and non-surgical therapies in advanced Parkinson's disease: a narrative review and call to action.
   J Neural Transm (Vienna). 2026 Aug 1. doi: 10.1007/s00702-026-03251.
   PubMed         Abstract available
   
   

   
   Mov Disord

8. KUBOTA GT, Parmera JB, Deltreggia M, Martins PN, et al
   Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.
   Mov Disord. 2026 Aug 7. doi: 10.1002/mds.70449.
   PubMed         Abstract available
   
   
9. YUSUFUJIANG A, Zeng S, Li H
   Type 2 alpha-Synuclein Seed Amplification as a Diagnostic Reassessment Signal in Parkinson's Progression Markers Initiative Parkinson's Disease.
   Mov Disord. 2026 Aug 6. doi: 10.1002/mds.70471.
   PubMed        
   
   
10. ESPAY AJ, Cardoso F, Frucht SJ, Imarisio A, et al
    What Does alpha-Syn-SAA-Negative Parkinson's Disease Reveal About the Proposed "Biological Definition" of Parkinson's Disease?
    Mov Disord. 2026 Aug 4. doi: 10.1002/mds.70439.
    PubMed        
    
    
11. BROOKER SM, Marek K, Poston KL
    Reply to: "What Does alpha-Syn-SAA-Negative Parkinson's Disease Reveal about the Proposed "Biological Definition" of Parkinson's Disease?".
    Mov Disord. 2026 Aug 4. doi: 10.1002/mds.70438.
    PubMed        
    
    
12. PERCETTI M, Yahya V, Fonzo AD, Monfrini E, et al
    Reply to: Complementary Mitochondrial and alpha-Synuclein Signatures Refine Biological Stratification of Parkinson's Disease.
    Mov Disord. 2026 Aug 4. doi: 10.1002/mds.70436.
    PubMed        
    
    
13. FITZGERALD JC, May P, Grunewald A
    Complementary Mitochondrial and alpha-Synuclein Signatures Refine Biological Stratification of Parkinson's Disease.
    Mov Disord. 2026 Aug 4. doi: 10.1002/mds.70437.
    PubMed        
    
    
14. KANAGASINGAM S, Parlar SC, Liu L, Gan-Or Z, et al
    Rare-Variant Burden Analysis of Dystonia Genes in Parkinson's Disease.
    Mov Disord. 2026 Aug 1. doi: 10.1002/mds.70463.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

15. ALBERQUILLA S, Prieto CS, Serrais PM, Murer MG, et al
    Dopamine D2 receptor dependent and independent structural, intrinsic and synaptic adaptations in experimental parkinsonism.
    Neurobiol Dis. 2026 Aug 8:107569. doi: 10.1016/j.nbd.2026.107569.
    PubMed         Abstract available
    
    

    
    PLoS One

16. SHAHRIAR KA
    Uncertainty-aware personalized estimation of Parkinson's disease severity from longitudinal speech.
    PLoS One. 2026;21:e0343191.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum